Life Science REIT (LON:LABS) Trading Up 3.2% - Still a Buy?

Key Points

• Life Science REIT plc saw its stock price increase by 3.2% during Wednesday's mid-day trading, reaching GBX 41.50 ($0.56).
• The company's market capitalization stands at £145.25 million, with a P/E ratio of -1,037.50 and a beta of 0.08, indicating strong volatility.
• Life Science REIT is a closed-ended REIT that began trading on the London Stock Exchange on November 19, 2021.

Life Science REIT plc (LON:LABS - )'s stock price was up 3.2% during mid-day trading on Wednesday . The stock traded as high as GBX 41.50 ($0.56) and last traded at GBX 41.50 ($0.56). Approximately 540,591 shares traded hands during trading, a decline of 24% from the average daily volume of 711,862 shares. The stock had previously closed at GBX 40.20 ($0.54).

Life Science REIT Price Performance

The company has a market cap of £145.25 million, a P/E ratio of -1,037.50 and a beta of 0.08. The company has a 50 day moving average of GBX 40.17 and a 200-day moving average of GBX 41.59.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.